Videos

Marcella shares how she met her diagnosis of multiple myeloma as Kenneth Shain, M.D., Ph.D., considers her experience in relation to other patients with multiple myeloma.

View the full CURE® Educated Patient® Webinar: Individualized Treatment for Small Cell Lung Cancer on demand.

View the full CURE® Educated Patient® Webinar: Stomach Cancer 101 Series: Part II - Treatment on demand.

Combining PI3 kinase inhibitors with BTK inhibitors can mitigate side effects traditionally seen with PI3 kinase inhibitors, according to recent research.

Latasha Jordan and Aditya Bardia, M.D., MPH, share advice for patients and caregivers on the importance of a positive outlook and attitude when living with triple-negative breast cancer.

A triple-negative breast cancer (TNBC) survivor, Latasha Jordan, considers the positive impact her support network has had on her treatment; and Aditya Bardia, M.D., MPH, emphasizes the importance of social support systems for patients with TNBC.

Latasha Jordan discusses her experience in a clinical trial with sacituzumab govitecan and comments on the side effects she experienced as well as the overall impact on her quality of life.

An expert oncologist highlights the importance of discussing clinical trial options with patients and comments on the recent FDA approval of sacituzumab govitecan in triple-negative breast cancer based on the ASCENT 3 trial.

A patient with triple-negative breast cancer, Latasha Jordan, reflects on the mental and emotional challenges she faced when she learned of her disease progression and shares her positive experience with physician referral thereafter.

A leader in breast oncology and a triple-negative breast cancer survivor discuss the role of active surveillance for post-surgical disease progression and emphasize the importance of support from health care providers after recurrence.

Aditya Bardia, M.D., MPH, and triple-negative breast cancer survivor, Latasha Jordan, discuss the importance of shared decision-making when considering mastectomy or lumpectomy and radiation for triple-negative breast cancer.

Latasha Jordan discusses her experience with neoadjuvant chemotherapy, and an expert in the management of breast cancer, Aditya Bardia, M.D., MPH, reviews common side events associated with systemic treatment.

Mel Mann, the longest living person who participated in the clinical trial for Gleevec – which was approved by the FDA just over 20 years ago – shares what he would tell his younger self.

Liposarcoma survivor Arianne Missimer discusses the training process for ‘American Ninja Warrior’ and how she felt the day of competition.

View the full CURE Educated Patient Lung Cancer Summit on demand.

View the full CURE Educated Patient Lung Cancer Summit on demand.

View the full CURE Educated Patient Lung Cancer Summit on demand.

More people are aware of the disparities LGBTQ patients face, but prohibitive legislature could be moving the needle backward when it comes to equality in care.

A survivor shares how she chose to approach her mindset during cancer treatments to keep herself from spiraling.

View the full CURE Educated Patient Leukemia Summit on demand.

A survivor of osteosarcoma who underwent treatment in the 1960s in a segregated hospital ward, shares how he was able to find strength during that time.

CURE spoke with Dr. Rajiit Rampal, on behalf of the MPN Research Foundation, about MPN symptoms and their management.

CURE spoke with Brandon Goetzman, board member from the MPN Research Foundation, on elevating the patient’s voice when it comes to their care for myeloproliferative neoplasms.

CURE spoke with Dr. Gabriela Hobbs, on behalf of the MPN Research Foundation, about the need for clinical trial education for patients with myeloproliferative neoplasms.

CURE spoke with Dr. Rajiit Rampal, on behalf of the MPN Research Foundation, about disease progression in myeloproliferative neoplasms.

CURE spoke with Dr. Gabriela Hobbs, on behalf of the MPN Research Foundation, about currently available treatment options, as well as those under clinical investigation, for patients with myeloproliferative neoplasms.

Rob Paulsen is the voice behind many beloved cartoon characters, but after receiving a cancer diagnosis, he discovered a whole new way to relate to others.

Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.

The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.

Dr Thomas E. Hutson comments on the rationale for using combination immune therapy, as well as a combination of immune therapy and an oral VEGF inhibitor for initial treatment of RCC.